𝔖 Bobbio Scriptorium
✦   LIBER   ✦

B-cell chronic lymphocytic leukaemia: Prognostic value of the immunophenotype and the clinico-haematological features

✍ Scribed by Alberto Orfao; Marcos Gonzalez; J. San Fernando Miguel; Agustin Rios; M. Consuelo Canizo; Jose Hernandez; M. Lourdes Maricato; Antonio Lopez Borrasca


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
522 KB
Volume
31
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


Sixty-two previously untreated patients with B-cell chronic lymphocytic leukaemia were analysed to study the prognostic value of both the immunologic phenotype and the clinicobiologic characteristics. Univariate studies showed that none of the immunological markers analysed, sheep-rosette, mouse-rosette, slg, and HLNDR, CD20, FMC7, CD5, and CD9 antigens, had a significant influence on survival. On the other hand, several clinical and haematological characteristics were identified as being associated with survival: 1) clinical features-presence of lymphadenopathies (P < .05) and hepatomegaly and/or splenomegaly (P < .04); 2) haematologic parameters-presence of anaemia andlor thrombopenia (P < .05), the absolute peripheral blood lymphocyte count (P < .03), and the presence of hypogammaglobulinemia (P < .08); 3) biochemical parameters-serum uric acid (P < .03); and 4) bone marrow histopathological features-biopsy pattern (P < .04) and the percentage of lymphocytes in bone marrow aspirate (P < .03). Both the Rai staging and the International Workshop on CLL staging systems were effective in identifying groups of patients with significantly different prognoses (P < .05). Multivariate regression analysis demonstrated that the combination of three clinicopathologic characteristics (bone marrow histopathologic pattern, absolute peripheral blood lymphocyte count, and the presence or not of hypogammaglobulinaemia) had the strongest predictive relationship with survival time.

In summary, our findings show that the clinicobiological and anatomopathologic parameters have much more prognostic relevance than the immunological markers analysed in the present study.


📜 SIMILAR VOLUMES


Decision-tree approach to the immunophen
✍ Mašić, Nikola; Gagro, Alenka; Rabatić, Sabina; Sabioncello, Ante; Dašić, Gorana; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Use of a nonlinear prediction method, such as machine learning, is a valuable choice in predicting progression rate of disease when applied to the highly variable and correlated biological data such as those in patients with chronic lymphocytic leukemia (CLL). In this work, decision-tree approach to

A scoring system based on the expression
✍ Antonella Zucchetto; Riccardo Bomben; Michele Dal Bo; Paolo Sonego; Paola Nanni; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 1 views

## Abstract We have previously identified 12 surface antigens whose differential expression represented the signature of B‐cell chronic lymphocytic leukemia (B‐CLL) subsets with different prognosis. In the present study, expression data for these antigens, as determined in 137 B‐CLL cases, all with

Impact of trisomy 12, del(13q), del(17p)
✍ Sandra Quijano; Antonio López; Ana Rasillo; José María Sayagués; Susana Barrena; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Abstract B‐cell chronic lymphocytic leukemia (B‐CLL) is a well‐defined clinical entity with heterogeneous molecular and cytogenetic features. Here, we analyze the impact of trisomy 12, del(13q), del(17p), and del(11q) as determined by interphase fluorescence in situ hybridization analysis of pur